Avidity Partners Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.86M | Buy |
94,500
+17,500
| +23% | +$1.83M | 1.97% | 19 |
|
|
2025
Q1 | $8.98M | Sell |
77,000
-111,000
| -59% | -$12.9M | 1.71% | 19 |
|
|
2024
Q4 | $15.9M | Sell |
188,000
-108,100
| -37% | -$9.15M | 1.56% | 27 |
|
|
2024
Q3 | $26.6M | Sell |
296,100
-79,900
| -21% | -$7.18M | 1.36% | 30 |
|
|
2024
Q2 | $30.3M | Sell |
376,000
-55,000
| -13% | -$4.43M | 1.29% | 30 |
|
|
2024
Q1 | $34.4M | Sell |
431,000
-28,400
| -6% | -$2.27M | 1.11% | 33 |
|
|
2023
Q4 | $36.6M | Buy |
459,400
+162,600
| +55% | +$12.9M | 1.33% | 35 |
|
|
2023
Q3 | $20.7M | Sell |
296,800
-248,200
| -46% | -$17.3M | 0.84% | 47 |
|
|
2023
Q2 | $39.2M | Sell |
545,000
-74,200
| -12% | -$5.33M | 1.37% | 31 |
|
|
2023
Q1 | $38.2M | Sell |
619,200
-50,800
| -8% | -$3.13M | 1.27% | 29 |
|
|
2022
Q4 | $51.7M | Sell |
670,000
-868,600
| -56% | -$67M | 1.12% | 29 |
|
|
2022
Q3 | $68.7M | Buy |
+1,538,600
| New | +$68.7M | 1.4% | 24 |
|
|
2022
Q2 | – | Sell |
-711,000
| Closed | -$29.4M | – | 84 |
|
|
2022
Q1 | $29.4M | Sell |
711,000
-64,000
| -8% | -$2.65M | 0.61% | 42 |
|
|
2021
Q4 | $29.3M | Buy |
+775,000
| New | +$29.3M | 0.62% | 49 |
|
|
2020
Q4 | – | Sell |
-118,000
| Closed | -$8.41M | – | 99 |
|
|
2020
Q3 | $8.41M | Sell |
118,000
-286,900
| -71% | -$20.4M | 0.39% | 47 |
|
|
2020
Q2 | $33.3M | Buy |
404,900
+207,900
| +106% | +$17.1M | 2.14% | 14 |
|
|
2020
Q1 | $11.6M | Buy |
+197,000
| New | +$11.6M | 1.6% | 23 |
|